Research Notes

The Jury is Still Out on Soy In the search for a breast cancer preventive, soy has been considered a promising candidate. But a review of research on soy's phytoestrogen genistein (K.B. Bouker, L. Hilakivi-Clarke, "Genistein: Does it prevent or promote breast cancer," Environmental Health Perspectives, 108:70-8, August 2000) is lukewarm on the compound's preventative capabilities. "There is no strong evidence that genistein would actually prevent breast cancer, but there is no strong evidence

Written byHarvey Black
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

In the search for a breast cancer preventive, soy has been considered a promising candidate. But a review of research on soy's phytoestrogen genistein (K.B. Bouker, L. Hilakivi-Clarke, "Genistein: Does it prevent or promote breast cancer," Environmental Health Perspectives, 108:70-8, August 2000) is lukewarm on the compound's preventative capabilities. "There is no strong evidence that genistein would actually prevent breast cancer, but there is no strong evidence that genistein would increase risk either," says Leena Hilakivi-Clarke, an associate professor of oncology at Georgetown University. Even though the evidence that genistein would increase breast cancer risk is not very persuasive, the authors do state that "studies indicating a potential breast cancer risk should not be taken lightly" and there is a "paramount" need to understand its potential to promote breast cancer. Genistein may play a role in promoting breast cancer, says Hilakivi-Clarke, when malignant cells are present in the breast. The ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies